The regulation of Bcl-2 expression in prostate cancer is complex and involves mechanisms such as DNA methylation and the influence of lineage plasticity factors like ASCL1 (Achaete-scute homolog 1). This evidence concerns the gene BCL2 and prostate carcinoma.